DLL3 DRUG-ANTIBODY CONJUGATES FOR THE TREATMENT OF TUMORS AT RISK OF NEUROENDOCRINE TRANSITION

MA45054AUndetermined Publication Date: 2019-03-27ABBVIE STEMCENTRX LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA45054
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-05-12
Filing Date
2017-05-19
Publication Date
2019-03-27
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.